|
|
|
|
|
| |
Clinical Trials Results - Marinol |
|
|
|
|
| Generic Name: |
Dronabinol |
| Form/Strengths: |
Capsules 2.5 mg, 5 mg, and 10 mg |
| NDA number: |
NDA 18-651 |
| US label: |
Marinol® |
|
|
|
|
|
| S175.2.101 |
A Double-blind, Randomized, Parallel-group, Pilot Study of Oral Dronabinol versus Placebo in the Treatment or Prevention of Highly Active Antiretroviral Therapy (HAART)-related Nausea and Vomiting |
Results summary
|
none available
|
| S175.3.102 |
A Double-blind, Randomized, Placebo-controlled, Parallel-group Efficacy Study of Oral Dronabinol Alone and in Combination with Ondansetron versus Ondansetron Alone in Subjects with Delayed Chemotherapy-induced Nausea and Vomiting |
Results summary
|
Meiri E, Jhangiani H, Vredenburgh JJ, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Current Medical Research and Opinion, 2007; 23:533-43
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
